AS26478 NOVARTIS-PHARMA - Novartis Pharmaceuticals

🇺🇸

ARINassigned

Announced Prefixes (BGP)

6total

6 IPv40 IPv6

IPv4 Addresses

Allocated (RIR)1,024

Announced (BGP)1,792

IPv6 Addresses

Allocated (RIR)0

Announced (BGP)0

Prefix Limit (IPv4)

Prefix Limit (IPv6)

Country

RIR

Status

assigned

Allocated

2002-09-25

Announced Prefixes

(BGP)6

Prefix	RPKI	IRR	Last Seen
86.117.47.0/24	Valid	Other IRRRIPE	2026-10-08
160.62.14.0/24MOAS	Valid	RIPE	2026-10-08
160.62.15.0/24	Valid	RIPE	2026-10-08
160.62.140.0/23	Valid	Other IRRRIPE	2026-10-08
162.86.66.0/24	No ROA	RIPE	2026-10-08
205.181.102.0/24	No ROA	-	2026-10-08

(RIR)3

Prefix	Country	RIR	Status
86.117.47.0/24	🇲🇽 MX	RIPE	assigned
160.62.140.0/23	🇺🇸 US	RIPE	assigned
162.86.66.0/24	🇺🇸 US	RIPE	assigned

(seen in AS paths)

Networks AS26478 hands its own prefixes to: transit providers, or peers at an exchange.

ASPA

No ASPA

External Links

What is an ASN?Autonomous systems, ASN ranges and how they are assigned
RPKI and route origin validationWhat the RPKI badges on the prefix list mean
ASPA explainedWhy AS26478 should publish an ASPA object
IPv4 transfers in the ARIN regionMonthly volume and the latest registry transfers
ASN data in AI agents and SIEMMCP server and API integrations

API

Returns ASN details, announced prefixes, and BGP routing data.

curl -s "https://api.ipctl.io/v1/asn/26478" | jq